NasdaqCM - Delayed Quote • USD
ESSA Pharma Inc. (EPIX)
At close: April 18 at 4:00 PM EDT
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Operating Cash Flow
-22,191.78
-19,781.72
-27,999.15
-25,415.61
-16,983.15
Investing Cash Flow
6,199.52
-3,527.15
-53,053.41
-35,014.77
-21,737.25
Financing Cash Flow
112.85
-68.16
252.74
141,990.75
41,776.63
End Cash Position
35,341.19
33,701.91
57,076.48
137,825.02
56,320.76
Issuance of Capital Stock
--
--
--
149,999.99
48,990.00
Repayment of Debt
-102.23
-136.87
-134.02
-100.28
-4,007.18
Free Cash Flow
-22,191.78
-19,781.72
-27,999.15
-25,415.61
-16,983.15
9/30/2020 - 3/13/2015
Yahoo Finance Plus Essential access required. Unlock Access
Related Tickers
MSCL.TO Satellos Bioscience Inc.
0.4900
-5.77%
ENGN enGene Holdings Inc.
14.17
-9.97%
CRVS Corvus Pharmaceuticals, Inc.
1.4100
+3.68%
BETR.CN BetterLife Pharma Inc.
0.1000
0.00%
ANTX AN2 Therapeutics, Inc.
2.3800
-4.03%
COGT Cogent Biosciences, Inc.
6.61
+1.23%
ANVS Annovis Bio, Inc.
9.85
+9.57%
RPHM Reneo Pharmaceuticals, Inc.
1.7600
-0.56%
COYA Coya Therapeutics, Inc.
8.44
+2.43%
RPTX Repare Therapeutics Inc.
3.0200
-5.92%